Sparstolonin B inhibits lipopolysaccharide-induced inflammation in 3T3-L1 adipocytes

European Journal of Pharmacology

Volumn 769, Issue , 2015, Pages 79-85

  Wang, Ming ^a   Xiu, Liangchang ^b   Diao, Jianxin ^a   Wei, Lianbo ^a   Sun, Jia ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

3T3 L1 adipocyte; LPS; NF B; Sparstolonin B; TLR4

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOBESITY AGENT; CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SPARSTOLONIN B; TOLL LIKE RECEPTOR 4; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CCL2 PROTEIN, MOUSE; FUSED HETEROCYCLIC RINGS; TLR4 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

3T3 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOBESITY ACTIVITY; ARTICLE; CELL VIABILITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING; ADIPOCYTE; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; CELL SURVIVAL; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; LIPID DIET; METABOLISM; MOUSE; PATHOLOGY;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; CHEMOKINE CCL2; DIET, HIGH-FAT; GENE EXPRESSION REGULATION; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; MICE; NF-KAPPA B; OBESITY; PPAR GAMMA; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84948994753     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.10.050     Document Type: Article

References (28)

1. A. Andoh, H. Takaya, T. Saotome, I. Shimada, K. Hata, Y. Araki, F. Nakamura, Y. Shintani, Y. Fujiyama, and T. Bamba Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts Gastroenterology 119 2000 211 219
2. J. Arko-Mensah, E. Julian, M. Singh, and C. Fernandez TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-gamma-induced killing of mycobacteria by murine macrophages Scand. J. immunol. 65 2007 148 157
3. J. Bassaganya-Riera, A.J. Guri, and R. Hontecillas Treatment of obesity-related complications with novel classes of naturally occurring PPAR agonists J. Obes. 2011 2011 897894
4. J.P. Bastard, M. Maachi, C. Lagathu, M.J. Kim, M. Caron, H. Vidal, J. Capeau, and B. Feve Recent advances in the relationship between obesity, inflammation, and insulin resistance Eur. Cytokine Netw. 17 2006 4 12
5. H.R. Bateman, Q.L. Liang, D.P. Fan, V. Rodriguez, and S.M. Lessner Sparstolonin B inhibits pro-angiogenic functions and blocks cell cycle progression in endothelial cells PLoS One 8 2013 10.1371/journal.pone.0070500
6. Y. Chen, L. Yang, and T.J. Lee Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation Biochem. Pharmacol. 59 2000 1445 1457
7. G. Gloire, S. Legrand-Poels, and J. Piette NF-kappaB activation by reactive oxygen species: fifteen years later Biochem. Pharmacol. 72 2006 1493 1505
8. G.S. Hotamisligil Endoplasmic reticulum stress and the inflammatory basis of metabolic disease Cell 140 2010 900 917
9. H. Kanda, S. Tateya, Y. Tamori, K. Kotani, K.I. Hiasa, R. Kitazawa, S. Kitazawa, H. Miyachi, S. Maeda, K. Egashira, and M. Kasuga MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity J. Clin. Investig. 116 2006 1494 1505
10. J.W. Kim, and C. Kim Inhibition of LPS-induced NO production by taurine chloramine in macrophages is mediated though Ras-ERK-NF-kappa B Biochem. Pharmacol. 70 2005 1352 1360
11. Q. Liang, F. Yu, X. Cui, J. Duan, Q. Wu, P. Nagarkatti, and D. Fan Sparstolonin B suppresses lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells Arch. Pharm. Res. 36 2013 890 896
12. Q.L. Liang, Q.A. Wu, J.H. Jiang, J.A. Duan, C. Wang, M.D. Smith, H. Lu, Q. Wang, P. Nagarkatti, and D.P. Fan Characterization of Sparstolonin B, a chinese herb-derived compound, as a selective toll-like receptor antagonist with potent anti-inflammatory properties J. Biol. Chem. 286 2011 26470 26479
13. Q. Liu, J. Wang, Q. Liang, D. Wang, Y. Luo, J. Li, J.S. Janicki, and D. Fan Sparstolonin B attenuates hypoxia-reoxygenation-induced cardiomyocyte inflammation Exp. Biol. Med. 239 2014 376 384
14. Y.C. Lu, W.C. Yeh, and P.S. Ohashi LPS/TLR4 signal transduction pathway Cytokine 42 2008 145 151
15. M. Maachi, L. Pieroni, E. Bruckert, C. Jardel, S. Fellahi, B. Hainque, J. Capeau, and J.P. Bastard Systemic low-grade inflammation is related to both circulating and adipose tissue TNF alpha, leptin and IL-6 levels in obese women Int. J. Obes. 28 2004 993 997
16. N. Ouchi, J.L. Parker, J.J. Lugus, and K. Walsh Adipokines in inflammation and metabolic disease Nat. Rev. Immunol. 11 2011 85 97
17. B.S. Park, D.H. Song, H.M. Kim, B.S. Choi, H. Lee, and J.O. Lee The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex Nature 458 2009 1191 U1130
18. M.Y. Park, and S.T. Mun Carnosic acid inhibits TLR4-MyD88 signaling pathway in LPS-stimulated 3T3-L1 adipocytes Nutr. Res. Pract. 8 2014 516 520
19. S. Quintero-Fabian, D. Ortuno-Sahagun, M. Vazquez-Carrera, and R.I. Lopez-Roa Alliin, a garlic (Allium sativum) compound, prevents LPS-induced inflammation in 3T3-L1 adipocytes Mediat. Inflamm. 2013 2013 381815
20. A. Rull, J. Camps, C. Alonso-Villaverde, and J. Joven Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism Mediat. Inflamm. 2010 2010
21. P. Sartipy, and D.J. Loskutoff Monocyte chemoattractant protein 1 in obesity and insulin resistance Proc. Natl. Acad. Sci. USA 100 2003 7265 7270
22. A. Shehzad, T. Ha, F. Subhan, and Y.S. Lee New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases Eur. J. Nutr. 50 2011 151 161
23. T. Suganami, K. Tanimoto-Koyama, J. Nishida, M. Itoh, X.M. Yuan, S. Mizuarai, H. Kotani, S. Yamaoka, K. Miyake, S. Aoe, Y. Kamei, and Y. Ogawa Role of the toll-like receptor 4/NF-kappa B pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages Arterioscler. Thromb. Vasc. Biol. 27 2007 84 91
24. K.E. Wellen, and G.S. Hotamisligil Obesity-induced inflammatory changes in adipose tissue J. Clin. Investig. 112 2003 1785 1788
25. K.E. Wellen, and G.S. Hotamisligil Obesity-induced inflammatory changes in adipose tissue J. Clin. Investig. 112 2003 1785 1788
26. B.E. Wisse The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity J. Am. Soc. Nephrol. 15 2004 2792 2800
27. H.Y. Xu, G.T. Barnes, Q. Yang, Q. Tan, D.S. Yang, C.J. Chou, J. Sole, A. Nichols, J.S. Ross, L.A. Tartaglia, and H. Chen Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J. Clin. Investig. 112 2003 1821 1830
28. J. Zhu, W. Yong, X. Wu, Y. Yu, J. Lv, C. Liu, X. Mao, Y. Zhu, K. Xu, X. Han, and C. Liu Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes Biochem. Biophys. Res. Commun. 369 2008 471 477